Malignant fibrous histiocytoma and fibrosarcoma of bone: A re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches

Virchows Archiv

Volumn 461, Issue 5, 2012, Pages 561-570

  Romeo, Salvatore ^a   Bovée, Judith V M G ^b   Kroon, Herman M ^b   Tirabosco, Roberto ^c   Natali, Cristina ^d   Zanatta, Lucia ^a   Sciot, Raf ^e   Mertens, Fredrik ^f   Athanasou, Nick ^g   Alberghini, Marco ^h   Szuhai, Karoly ^b   Hogendoorn, Pancras C W ^b   Dei Tos, Angelo Paolo ^a  

^a TREVISO REGIONAL HOSPITAL   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d Rovigo Regional Hospital   (Italy)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^h RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Bone neoplasm; Classification; Fibrosarcoma of bone; Malignant fibrous histiocytoma of bone

Indexed keywords

CALDESMON; CD163 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN S 100; SMOOTH MUSCLE ACTIN;

ADULT; AGED; ARTICLE; BONE TUMOR; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; EMBRYONAL RHABDOMYOSARCOMA; ENDOMETRIUM CARCINOMA; FEMALE; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERDIGITATING DENDRITIC CELL SARCOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MYOEPITHELIOMA; MYXOFIBROSARCOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; SPINDLE CELL SARCOMA; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DNA, NEOPLASM; EUROPE; FEMALE; FIBROSARCOMA; FOLLOW-UP STUDIES; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOSARCOMA; MALE; MIDDLE AGED; MYXOSARCOMA; OSTEOSARCOMA; RHABDOMYOSARCOMA, EMBRYONAL; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871610404     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1306-z     Document Type: Article

References (23)

1. Dei Tos AP (2006) Classification of pleomorphic sarcomas: where are we now? Histopathology 48(1):51-62
2. Bahrami A, Folpe AL (2010) Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol 34(10):1504-1513
3. Fletcher CDM, Unni KK, Mertens F (2002) WHO Classification of tumours. Pathology & genetics of tumours of soft tissue and bone. IARC, Lyon
4. Fletcher CDM (1992) Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16:213-228
5. Antonescu CR, Zhang L, Chang NE, Pawel BR, Travis W, Katabi N et al (2010) EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Gene Chromosomes Canc 49(12):1114-1124
6. Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke HJ, Hogendoorn PC (2009) The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res 15 (7):2259-2268
7. Nishida J, Sim FH, Wenger DE, Unni KK (1997) Malignant fibrous histiocytoma of bone. A clinicopathologic study of 81 patients. Cancer 79(3):482-493 (Pubitemid 27051772)
8. Antonescu CR, Erlandson RA, Huvos AG (1997) Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review. Am J Surg Pathol 21(11):1281-1294 (Pubitemid 27460855)
9. Petra M, Gibbons CL, Athanasou NA (2002) Leiomyosarcoma of bone arising in association with a bone infarct. Sarcoma 6(1):47- 50 (Pubitemid 34620888)
10. Raymond AK, Ayala AG, Knuutila S (2002) Conventional osteosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 264-270
11. Angervall L, Kindblom LG, Merck C (1977) Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 85A(2):127- 140 (Pubitemid 8049689)
12. Weiss SW, Enzinger FM (1977) Myxoid variant of malignant fibrous histiocytoma. Cancer 39:1672-1685 (Pubitemid 8107720)
13. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA et al (1996) Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 20(4):391-405 (Pubitemid 26113344)
14. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19(12):3045-3050 (Pubitemid 32565442)
15. Verbeke SL, Fletcher CD, Alberghini M, Daugaard S, Flanagan AM, Parratt T et al (2010) A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone. Am J Surg Pathol 34(6):777-783
16. Ueda T, Araki N, Mano M, Myoui A, Joyama S, Ishiguro S et al (2002) Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone. J Clin Pathol 55(11):853-858 (Pubitemid 35316254)
17. Erlandson RA, Antonescu CR (2004) The rise and fall of malignant fibrous histiocytoma. Ultrastruct Pathol 28(5-6):283-289 (Pubitemid 39657534)
18. Antonescu CR, Erlandson RA, Huvos AG (2000) Primary fibrosarcoma and malignant fibrous histiocytoma of bone - a comparative ultrastructural study: evidence of a spectrum of fibroblastic differentiation. Ultrastruct Pathol 24(2):83-91 (Pubitemid 30241159)
19. Montgomery E, Fisher C (2001) Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 38(6):499-509 (Pubitemid 32863002)
20. Bernardo ME, Emons JA, Karperien M, Nauta AJ, Willemze R, Roelofs H et al (2007) Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res 48(3):132-140 (Pubitemid 46863131)
21. Mertens F, Romeo S, Bovée JVMG, Tirabosco R, Athanasou NA, Alberghini M et al (2011) Reclassification and subtyping of socalled malignant fibrous histiocytoma of bone: comparison with cytogenetic features. Clin Sarcoma Res 1(1):10
22. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B et al (2007) Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 25(19):2755-2763 [corrected] (Pubitemid 47123184)
23. Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C et al (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20(12):2824-2831 (Pubitemid 34651511)